TALZENNA + XTANDI is the first PARP inhibitor plus ARPI combination to demonstrate statistically significant and clinically meaningful improvement in overall survival (OS) in patients with ...

A total of 805 patients were randomly assigned in cohort 1 to receive Talzenna 0.5 milligrams (mg) with Xtandi 160 mg per day (402 patients) or placebo and Xtandi 160 mg per day (403 patients).

Patients with castrate testosterone levels were randomized to receive TALZENNA 0.5 mg/day plus XTANDI ... TALZENNA in combination with XTANDI is now approved in more than 40 countries globally ...

In mCRPC patients, Talzenna + Xtandi cut death risk by 20%, extending median OS to 45.8 months vs. 37.0 months with Xtandi alone. In HRR-mutated mCRPC, Talzenna + Xtandi reduced death risk by 38% ...

Patients with castrate testosterone levels were randomized to receive TALZENNA 0.5 mg/day plus ... use with XTANDI for patients with mCRPC, with or without gene mutations. TALZENNA in combination with ...

Pfizer (NYSE:PFE) reported positive results from a Phase 3 study of its drug Talzenna in combination with Xtandi in the treatment of certain patients with prostate cancer. The study, called ...

After more than four years of median follow-up (52.5 months), the median OS in cohort 1 was 45.8 months with TALZENNA in combination with XTANDI ... %), fatigue (49% vs 40%), platelets decreased ...

(RTTNews) - Pfizer (PFE), on Thursday announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA or talazoparib in combination with XTANDI or enzalutamide for the treatment of ...

Following an FDA approval in 2023 that allows Talzenna to be used with Pfizer’s Astellas-partnered Xtandi to treat metastatic castration-resistant prostate cancer (mCRPC) cases that have ...

Although MG hasn’t revealed exact specifications yet, going by the dimensions of the international-spec D90 Max, the Majestor could measure 5,046mm in length, 2,016mm in width and 1,876mm in ...

Her advice: “Take time to acknowledge your accomplishments – you deserve it! Reflect on the attributes and actions that have led to your accomplishments so that you can replicate [them ...

We already know that Tecno is working on the Camon 40 series of smartphones. While there is no official word regarding its launch, new certification sighting has hinted at its imminent release.